|
humans |
37 |
|
hepatocellular carcinoma |
34 |
|
cell line, tumor |
31 |
|
animals |
30 |
|
mice |
28 |
|
mice, nude |
28 |
|
cell proliferation |
24 |
|
male |
21 |
|
liver neoplasms - metabolism - pathology |
20 |
|
carcinoma, hepatocellular - metabolism - pathology |
19 |
|
reverse transcriptase polymerase chain reaction |
19 |
|
transfection |
18 |
|
transplantation, heterologous |
18 |
|
up-regulation |
18 |
|
adult |
17 |
|
blotting, western |
17 |
|
tumor cells, cultured |
17 |
|
immunohistochemistry |
16 |
|
aged |
15 |
|
cell movement |
15 |
|
female |
15 |
|
middle aged |
15 |
|
apoptosis |
14 |
|
gene expression |
14 |
|
peptidyl-prolyl-isomerase |
14 |
|
pin1 |
14 |
|
β-catenin |
14 |
|
adolescent |
13 |
|
medical sciences |
13 |
|
neoplasm transplantation |
13 |
|
disease models, animal |
12 |
|
disease progression |
12 |
|
hcc |
12 |
|
beta catenin |
11 |
|
carcinoma, hepatocellular - etiology - genetics - metabolism |
11 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology - virology |
11 |
|
cyclin d1 - biosynthesis - genetics |
11 |
|
cytoskeletal proteins - genetics |
11 |
|
gene expression profiling |
11 |
|
liver neoplasms - genetics - metabolism - pathology - virology |
11 |
|
peptidylprolyl isomerase - biosynthesis - genetics |
11 |
|
trans-activators - genetics |
11 |
|
antigens, cd - genetics - metabolism |
10 |
|
cell division |
10 |
|
dna primers |
10 |
|
down-regulation |
10 |
|
down-regulation - drug effects |
10 |
|
gene expression regulation, neoplastic |
10 |
|
metastasis |
10 |
|
molecular biology |
10 |
|
molecular pathology |
10 |
|
protein binding |
10 |
|
rna, messenger - metabolism |
10 |
|
signal transduction |
10 |
|
signaling |
10 |
|
survival |
10 |
|
xenograft model antitumor assays |
10 |
|
antigens, cd - metabolism |
9 |
|
chemoresistance |
9 |
|
drug resistance, neoplasm |
9 |
|
glycoproteins - metabolism |
9 |
|
immunosuppressive agents - therapeutic use |
9 |
|
inhibitor of differentiation protein 1 |
9 |
|
liver neoplasms - genetics - metabolism - pathology |
9 |
|
liver transplantation |
9 |
|
map kinase signaling system - drug effects - physiology |
9 |
|
mapk |
9 |
|
mice, scid |
9 |
|
peptides - metabolism |
9 |
|
prostate cancer |
9 |
|
repressor proteins |
9 |
|
signal transduction - drug effects - physiology |
9 |
|
sphingosine - analogs & derivatives |
9 |
|
apoptosis - drug effects |
8 |
|
base sequence |
8 |
|
carcinoma, hepatocellular - genetics - metabolism |
8 |
|
carcinoma, hepatocellular - metabolism - pathology - secondary |
8 |
|
carrier proteins - metabolism |
8 |
|
cd133 |
8 |
|
cell cycle proteins - genetics |
8 |
|
cell differentiation |
8 |
|
cell division - physiology |
8 |
|
chemokine cxcl1 - physiology |
8 |
|
cyclin-dependent kinase inhibitor p16 - genetics - metabolism |
8 |
|
early growth response protein 1 |
8 |
|
glycoproteins - deficiency - genetics - metabolism |
8 |
|
glycoproteins - genetics - metabolism |
8 |
|
heme oxygenase-1 |
8 |
|
immediate-early proteins |
8 |
|
interleukin-8 - deficiency - genetics - physiology |
8 |
|
liver neoplasms - genetics - metabolism |
8 |
|
liver regeneration |
8 |
|
microscopy, electron |
8 |
|
neoplasm invasiveness |
8 |
|
nitric oxide synthase type ii |
8 |
|
propylene glycols - pharmacology |
8 |
|
rac gtp-binding proteins - metabolism |
8 |
|
rats |
8 |
|
retinoblastoma protein - genetics - metabolism |
8 |
|
rna, messenger - genetics - metabolism |
8 |
|
survival analysis |
8 |
|
transcription factors - genetics - metabolism - physiology |
8 |
|
anti-steatosis |
7 |
|
beta catenin - genetics |
7 |
|
cadherins - metabolism |
7 |
|
cancer metastasis |
7 |
|
cancer stem cells |
7 |
|
carcinoma, hepatocellular - drug therapy - physiopathology - secondary |
7 |
|
carcinoma, hepatocellular - enzymology - genetics |
7 |
|
carcinoma, hepatocellular - genetics |
7 |
|
carcinoma, hepatocellular - genetics - mortality - secondary |
7 |
|
caveolin 1 - genetics - metabolism |
7 |
|
caveolin-1 |
7 |
|
cell line |
7 |
|
cell proliferation - drug effects |
7 |
|
cell survival signaling |
7 |
|
cell transformation, neoplastic - metabolism |
7 |
|
clone cells |
7 |
|
cyclin d1 - genetics |
7 |
|
disease-free survival |
7 |
|
dna-binding proteins - metabolism |
7 |
|
endothelial cells - drug effects |
7 |
|
endothelin-1 - genetics |
7 |
|
epithelial cells - metabolism - physiology |
7 |
|
fatty liver - pathology - surgery |
7 |
|
focal adhesion kinase 2 - metabolism |
7 |
|
gastroenterology medical sciences |
7 |
|
gene expression regulation, neoplastic - genetics |
7 |
|
gene knockdown techniques |
7 |
|
gene silencing |
7 |
|
glycogen synthase kinase 3 - metabolism |
7 |
|
graft rejection - blood - drug therapy - pathology |
7 |
|
graft survival - drug effects |
7 |
|
hepatectomy |
7 |
|
hepatic microcirculation |
7 |
|
hong kong - epidemiology |
7 |
|
hypoxia-inducible factor 1, alpha subunit - metabolism |
7 |
|
immunosuppressive agents - pharmacology |
7 |
|
in situ nick-end labeling |
7 |
|
inhibitor of differentiation protein 1 - antagonists & inhibitors - genetics - metabolism |
7 |
|
invasiveness |
7 |
|
liver - metabolism - pathology |
7 |
|
liver neoplasms - drug therapy - physiopathology - secondary |
7 |
|
liver neoplasms - enzymology - genetics |
7 |
|
liver neoplasms - genetics |
7 |
|
liver neoplasms - genetics - mortality - pathology |
7 |
|
marginal graft |
7 |
|
mice, inbred balb c |
7 |
|
microarray analysis - methods |
7 |
|
neoplasm invasiveness - genetics |
7 |
|
neoplasm proteins - genetics |
7 |
|
neovascularization, pathologic - metabolism |
7 |
|
nitric oxide synthase - metabolism |
7 |
|
nuclear proteins - metabolism |
7 |
|
oligodeoxyribonucleotides, antisense - pharmacology - therapeutic use |
7 |
|
oncology |
7 |
|
organ size |
7 |
|
peptidylprolyl isomerase - genetics |
7 |
|
proline-rich tyrosine kinase2 (pyk2) |
7 |
|
propylene glycols - therapeutic use |
7 |
|
protein structure, tertiary |
7 |
|
proto-oncogene proteins c-akt |
7 |
|
rats, inbred lew |
7 |
|
rats, sprague-dawley |
7 |
|
recurrence |
7 |
|
rna interference |
7 |
|
rna, neoplasm - genetics |
7 |
|
stat5 transcription factor - biosynthesis - genetics - metabolism |
7 |
|
statistics as topic |
7 |
|
structure-activity relationship |
7 |
|
surgery |
7 |
|
survival rate |
7 |
|
tissue array analysis |
7 |
|
tocotrienol |
7 |
|
transcription factors - metabolism |
7 |
|
transcriptional activation - physiology |
7 |
|
transfection - methods |
7 |
|
tumourigenesis |
7 |
|
twist transcription factor - metabolism |
7 |
|
up-regulation - genetics |
7 |
|
vascular endothelial growth factor a - genetics - metabolism - secretion |
7 |
|
young adult |
7 |
|
akt signaling pathway |
6 |
|
amino acid motifs |
6 |
|
antigens, cd34 - metabolism |
6 |
|
antigens, differentiation - metabolism |
6 |
|
antineoplastic agents - pharmacology |
6 |
|
bcl-x protein - genetics - metabolism |
6 |
|
cadherins - genetics - metabolism |
6 |
|
carcinogenicity tests |
6 |
|
carcinoma, hepatocellular - drug therapy - metabolism - secondary |
6 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology |
6 |
|
carcinoma, hepatocellular - genetics - mortality - pathology - surgery - therapy |
6 |
|
carcinoma, hepatocellular - genetics - prevention and control - secondary |
6 |
|
cdna microarray |
6 |
|
cell cycle - genetics |
6 |
|
cell cycle proteins - metabolism |
6 |
|
cell separation |
6 |
|
cell transformation, neoplastic - genetics - metabolism |
6 |
|
cyclin d1 - metabolism |
6 |
|
cyclin-dependent kinase inhibitor p21 |
6 |
|
cyclin-dependent kinase inhibitor p27 |
6 |
|
endothelin-1 - genetics - metabolism |
6 |
|
enzyme inhibitors - pharmacology |
6 |
|
flow cytometry |
6 |
|
focal adhesion kinase |
6 |
|
fty720 |
6 |
|
g1 phase - drug effects |
6 |
|
gene expression regulation |
6 |
|
gene expression regulation - physiology |
6 |
|
genes, p53 - genetics |
6 |
|
heme oxygenase (decyclizing) - genetics |
6 |
|
hepatectomy - adverse effects |
6 |
|
hepatectomy - methods |
6 |
|
hepatitis b - complications - genetics - metabolism - pathology - virology |
6 |
|
hepatocellular carcinoma (hcc) |
6 |
|
homeodomain proteins - antagonists and inhibitors - genetics - metabolism |
6 |
|
homeodomain proteins - genetics - metabolism |
6 |
|
homeoprotein six1 |
6 |
|
hypertension, portal - etiology - physiopathology |
6 |
|
interference |
6 |
|
kidney neoplasms - genetics - prevention and control - secondary |
6 |
|
ligation |
6 |
|
liver - blood supply - metabolism - pathology - surgery |
6 |
|
liver - metabolism - pathology - physiopathology |
6 |
|
liver circulation - physiology |
6 |
|
liver neoplasms - blood supply - surgery - ultrastructure |
6 |
|
liver neoplasms - genetics - mortality - pathology - surgery - therapy |
6 |
|
liver neoplasms, experimental - drug therapy - metabolism - pathology |
6 |
|
liver neoplasms, experimental - genetics - pathology - prevention and control |
6 |
|
liver neoplasms, experimental - metabolism - pathology - surgery |
6 |
|
liver neoplasms, experimental - metabolism - pathology - virology |
6 |
|
liver transplantation - adverse effects - pathology - physiology |
6 |
|
liver transplantation - pathology - physiology |
6 |
|
living donors |
6 |
|
lung neoplasms - etiology - metabolism - secondary |
6 |
|
map kinase signaling system - drug effects |
6 |
|
microcirculation |
6 |
|
mitogen-activated protein kinase 1 - antagonists & inhibitors - metabolism |
6 |
|
mitogen-activated protein kinase 3 - antagonists & inhibitors - metabolism |
6 |
|
muscle development |
6 |
|
neoplasm metastasis |
6 |
|
neoplasm recurrence, local - etiology - metabolism - pathology |
6 |
|
neovascularization, pathologic |
6 |
|
neovascularization, pathologic - prevention & control |
6 |
|
nitric oxide synthase - genetics - metabolism |
6 |
|
nitric oxide synthase type iii |
6 |
|
p21/waf1 |
6 |
|
p53 |
6 |
|
pathologic tumour-node-metastasis (ptnm) stage |
6 |
|
peptidylprolyl isomerase - genetics - metabolism |
6 |
|
phenotype |
6 |
|
phosphatidylinositol 3-kinases - antagonists & inhibitors - metabolism |
6 |
|
phosphatidylinositol 3-kinases - metabolism |
6 |
|
phosphorylation |
6 |
|
phosphorylation - drug effects |
6 |
|
progression |
6 |
|
proliferating cell nuclear antigen |
6 |
|
proliferating cell nuclear antigen - analysis |
6 |
|
proline |
6 |
|
prostatic neoplasms - pathology |
6 |
|
protein-serine-threonine kinases - metabolism |
6 |
|
proteins - genetics |
6 |
|
proto-oncogene proteins - metabolism |
6 |
|
proto-oncogene proteins c-myc - genetics - metabolism |
6 |
|
rac gtp-binding proteins - chemistry - metabolism |
6 |
|
reproducibility of results |
6 |
|
rna, small interfering - pharmacology |
6 |
|
serine |
6 |
|
short hairpin rna (shrna) |
6 |
|
signal transduction - physiology |
6 |
|
six1 |
6 |
|
stem cells - metabolism - pathology |
6 |
|
time factors |
6 |
|
trans-activators - genetics - metabolism |
6 |
|
transcription factor rela - genetics - metabolism |
6 |
|
transcription, genetic |
6 |
|
transcriptional activation |
6 |
|
transplantation, isogeneic |
6 |
|
treatment outcome |
6 |
|
tumor markers, biological - metabolism |
6 |
|
tumor suppressor protein p53 - metabolism |
6 |
|
tumor suppressor proteins - metabolism |
6 |
|
tumor-initiating cells |
6 |
|
vascular endothelial growth factor a - metabolism |
6 |
|
venous infiltration |
6 |
|
wound healing |
6 |
|
acute-phase reaction |
5 |
|
adenosine - chemistry |
5 |
|
aged, 80 and over |
5 |
|
aggressiveness |
5 |
|
akt |
5 |
|
akt survival pathway |
5 |
|
alanine transaminase - blood |
5 |
|
allopurinol - chemistry |
5 |
|
antigens, cd - biosynthesis - physiology |
5 |
|
apolipoprotein c-iii |
5 |
|
apolipoproteins c - metabolism |
5 |
|
aspartate aminotransferases - blood |
5 |
|
biopsy |
5 |
|
carcinoma, hepatocellular - metabolism |
5 |
|
carcinoma, squamous cell - genetics - pathology |
5 |
|
carrier proteins - genetics |
5 |
|
ccaat-enhancer-binding proteins - physiology |
5 |
|
cell survival - drug effects - physiology |
5 |
|
chemokine cxcl2 |
5 |
|
chemokines, cxc - metabolism |
5 |
|
chemoprevention - methods |
5 |
|
chromans - pharmacology |
5 |
|
computer systems |
5 |
|
cytokines - blood - genetics |
5 |
|
dna primers - chemistry |
5 |
|
dna probes |
5 |
|
dna-binding proteins - physiology |
5 |
|
drug delivery systems - methods |
5 |
|
drug resistance, neoplasm - physiology |
5 |
|
e-cadherin |
5 |
|
endothelin-1 - blood - genetics |
5 |
|
endothelin-1 - metabolism |
5 |
|
energy metabolism - drug effects - physiology |
5 |
|
enzyme-linked immunosorbent assay |
5 |
|
epidermal growth factor - metabolism |
5 |
|
extracellular signal-regulated map kinases - metabolism |
5 |
|
fascin |
5 |
|
fibrosis - drug therapy - pathology |
5 |
|
glucagon - blood |
5 |
|
glutathione - chemistry |
5 |
|
glycoproteins - biosynthesis - physiology |
5 |
|
graft survival - drug effects - genetics |
5 |
|
graft survival - drug effects - immunology - physiology |
5 |
|
graft survival - physiology |
5 |
|
heme oxygenase (decyclizing) - biosynthesis |
5 |
|
hepatic stellate cell (hsc) |
5 |
|
hepatocytes - cytology |
5 |
|
hsp70 heat-shock proteins - genetics |
5 |
|
hsp70 heat-shock proteins - metabolism |
5 |
|
hypertension, portal - etiology - prevention & control |
5 |
|
hypoglycemic agents - pharmacology |
5 |
|
immediate-early proteins - metabolism |
5 |
|
immunosuppressive agents - administration and dosage |
5 |
|
inflammation |
5 |
|
insulin - chemistry - pharmacology |
5 |
|
insulin receptor substrate proteins |
5 |
|
intercellular signaling peptides and proteins - metabolism |
5 |
|
interleukin-10 - biosynthesis |
5 |
|
intracellular signaling peptides and proteins |
5 |
|
ischemia-reperfusion injury |
5 |
|
liver - anatomy & histology |
5 |
|
liver - anatomy & histology - drug effects - ultrastructure |
5 |
|
liver - anatomy & histology - pathology - physiopathology |
5 |
|
liver - drug effects - injuries - metabolism |
5 |
|
liver - metabolism - ultrastructure |
5 |
|
liver cirrhosis |
5 |
|
liver cirrhosis, experimental - surgery |
5 |
|
liver neoplasms - drug therapy - enzymology |
5 |
|
liver transplantation - adverse effects |
5 |
|
liver transplantation - immunology |
5 |
|
liver transplantation - methods |
5 |
|
liver transplantation - physiology |
5 |
|
map kinase signaling system |
5 |
|
microfilament proteins - genetics |
5 |
|
models, animal |
5 |
|
mouth neoplasms - genetics - pathology |
5 |
|
neoplastic stem cells - drug effects |
5 |
|
neoplastic stem cells - drug effects - metabolism |
5 |
|
neoplastic stem cells - drug effects - pathology |
5 |
|
nf-kappa b - metabolism |
5 |
|
oligonucleotide array sequence analysis |
5 |
|
organ preservation |
5 |
|
organ preservation solutions - chemistry |
5 |
|
oscc |
5 |
|
p38 mitogen-activated protein kinases - metabolism |
5 |
|
peptides - physiology |
5 |
|
phosphoproteins - physiology |
5 |
|
polymerase chain reaction |
5 |
|
prostatic neoplasms - drug therapy - pathology - prevention and control |
5 |
|
protein-serine-threonine kinases - physiology |
5 |
|
protein-tyrosine kinases - physiology |
5 |
|
proteins - metabolism |
5 |
|
proteoglycans - pharmacology - therapeutic use |
5 |
|
proto-oncogene proteins - physiology |
5 |
|
proto-oncogene proteins c-akt - biosynthesis - physiology |
5 |
|
raf kinases - metabolism |
5 |
|
raffinose - chemistry |
5 |
|
receptors, endothelin - genetics |
5 |
|
reperfusion injury - drug therapy |
5 |
|
reperfusion injury - metabolism - physiopathology |
5 |
|
sirolimus - administration and dosage |
5 |
|
small-for-size graft |
5 |
|
smoking |
5 |
|
somatostatin - therapeutic use |
5 |
|
stem cell |
5 |
|
sterol regulatory element binding protein 1 |
5 |
|
stress, mechanical |
5 |
|
transcription factors - physiology |
5 |
|
transplantation, homologous |
5 |
|
tumorigenicity |
5 |
|
up-regulation - physiology |
5 |
|
vasoconstriction - physiology |
5 |
|
vitamin e |
5 |
|
vitamin e - analogs & derivatives - pharmacology |
5 |
|
adaptor proteins, signal transducing - metabolism |
4 |
|
adenosine |
4 |
|
aldehyde dehydrogenase - metabolism |
4 |
|
allopurinol |
4 |
|
antineoplastic agents - therapeutic use |
4 |
|
antineoplastic combined chemotherapy protocols - pharmacology |
4 |
|
cancer-associated fibroblasts (cafs) |
4 |
|
carboxypeptidase h - chemistry - genetics |
4 |
|
carcinoma, hepatocellular - enzymology - pathology |
4 |
|
carcinoma, hepatocellular - genetics - metabolism - secondary |
4 |
|
carcinoma, hepatocellular - pathology |
4 |
|
carcinoma, squamous cell - drug therapy - genetics - metabolism - pathology |
4 |
|
caveolin 1 - metabolism |
4 |
|
cell death - drug effects |
4 |
|
cell growth |
4 |
|
cell growth processes - drug effects |
4 |
|
cell movement - drug effects |
4 |
|
cell survival |
4 |
|
cisplatin - administration & dosage - pharmacology |
4 |
|
dna-binding proteins - genetics |
4 |
|
drug synergism |
4 |
|
drug-resistance |
4 |
|
electrophoresis, gel, two-dimensional |
4 |
|
epithelial cells - drug effects - pathology |
4 |
|
epithelium - metabolism |
4 |
|
fra1 |
4 |
|
glutathione |
4 |
|
graft survival - drug effects - physiology |
4 |
|
head and neck neoplasms - drug therapy - genetics - metabolism - pathology |
4 |
|
helix-loop-helix motifs |
4 |
|
hepatocyte growth factor (hgf) |
4 |
|
hey1 |
4 |
|
i-kappa b kinase - genetics - metabolism |
4 |
|
id-1 |
4 |
|
inhibitor of differentiation protein 1 - metabolism |
4 |
|
insulin - pharmacology |
4 |
|
isoenzymes - metabolism |
4 |
|
liver - drug effects - pathology |
4 |
|
liver circulation - drug effects |
4 |
|
liver function tests |
4 |
|
liver neoplasms - enzymology - pathology |
4 |
|
lymphatic metastasis |
4 |
|
map kinase signaling system - physiology |
4 |
|
mesoderm - drug effects - pathology |
4 |
|
mesoderm - metabolism |
4 |
|
microfilament proteins - genetics - metabolism |
4 |
|
mim-b |
4 |
|
mir-142-3p |
4 |
|
molecular sequence data |
4 |
|
neoplasm proteins - genetics - metabolism |
4 |
|
neoplasm proteins - metabolism |
4 |
|
neoplasm staging |
4 |
|
neoplastic stem cells - enzymology - pathology |
4 |
|
nf-kappa b - antagonists & inhibitors - biosynthesis - genetics - metabolism |
4 |
|
organ preservation - methods |
4 |
|
organ preservation solutions |
4 |
|
paclitaxel - pharmacology |
4 |
|
pentacyclic triterpenes |
4 |
|
post-translational modification |
4 |
|
prostatic neoplasms - metabolism - pathology |
4 |
|
protein isoforms |
4 |
|
proteomics |
4 |
|
raffinose |
4 |
|
real-time quantitative pc |
4 |
|
recombinant proteins - metabolism |
4 |
|
reperfusion injury - physiopathology |
4 |
|
rho gtpase |
4 |
|
rho-associated kinase |
4 |
|
rna, neoplasm - analysis |
4 |
|
sphere formation |
4 |
|
transcription factors - genetics - physiology |
4 |
|
triterpenes - administration & dosage - pharmacology |
4 |
|
tumor-initiating cells (t-ics) |
4 |
|
two-hybrid system techniques |
4 |
|
vascular endothelial growth factors - biosynthesis - metabolism |
4 |
|
wnt/β-catenin |
4 |
|
antigens, cd |
3 |
|
beta-galactosidase - metabolism |
3 |
|
bone marrow cells |
3 |
|
c8 |
3 |
|
carcinoma, hepatocellular - drug therapy |
3 |
|
carcinoma, hepatocellular - drug therapy - metabolism - pathology |
3 |
|
carcinoma, hepatocellular - metabolism - therapy |
3 |
|
cd24 antigen |
3 |
|
cd47 |
3 |
|
cdk1 |
3 |
|
cell division - drug effects |
3 |
|
cell renewal |
3 |
|
cisplatin |
3 |
|
cscs |
3 |
|
degradation |
3 |
|
dna - chemistry |
3 |
|
drug design |
3 |
|
gene therapy - methods |
3 |
|
genes, p53 |
3 |
|
glycoproteins |
3 |
|
hbx |
3 |
|
hemagglutinins - metabolism |
3 |
|
hepatocytes |
3 |
|
hepatocytes - drug effects - metabolism - pathology |
3 |
|
inhibitor of differentiation protein 1 - chemistry - metabolism |
3 |
|
liver - drug effects - metabolism - pathology |
3 |
|
liver cancer |
3 |
|
liver neoplasms - drug therapy |
3 |
|
liver neoplasms - drug therapy - metabolism - pathology |
3 |
|
liver neoplasms - metabolism - therapy |
3 |
|
neoplastic stem cells - drug effects - metabolism - pathology |
3 |
|
npm |
3 |
|
oligopeptides - metabolism |
3 |
|
oval cells |
3 |
|
p53: hepatocellular carcinoma |
3 |
|
pentacyclic triterpenes - therapeutic use |
3 |
|
peptides |
3 |
|
proteasome |
3 |
|
proteasome endopeptidase complex - metabolism |
3 |
|
protein processing, post-translational |
3 |
|
protein subunits - metabolism |
3 |
|
pten phosphohydrolase - physiology |
3 |
|
receptor, epidermal growth factor - genetics - metabolism |
3 |
|
receptor-mediated gene transfer system |
3 |
|
retroviridae - genetics |
3 |
|
sox9 |
3 |
|
stat3 protein |
3 |
|
stem cells - drug effects - metabolism - pathology |
3 |
|
thermodynamics |
3 |
|
trans-activators |
3 |
|
ubiquitination |
3 |
|
viral regulatory and accessory proteins - chemistry - metabolism |
3 |
|
adipocytes |
2 |
|
ampk |
2 |
|
antibiotics, antineoplastic - pharmacology |
2 |
|
apoptosis - drug effects - genetics |
2 |
|
blotting, southern |
2 |
|
carcinoma, hepatocellular - genetics - pathology |
2 |
|
caspases - genetics |
2 |
|
cdna array |
2 |
|
cell cycle - drug effects |
2 |
|
cell cycle proteins - biosynthesis |
2 |
|
cell division - genetics |
2 |
|
chemosensitivity |
2 |
|
cholecystokinin |
2 |
|
cisplatin - pharmacology |
2 |
|
dna damage - physiology |
2 |
|
dna fragmentation |
2 |
|
dna fragmentation - drug effects |
2 |
|
dna, complementary |
2 |
|
dox |
2 |
|
doxorubicin - pharmacology |
2 |
|
gene deletion |
2 |
|
gene expression profile |
2 |
|
gtpase-activating proteins |
2 |
|
hepatoma |
2 |
|
homozygote |
2 |
|
liver neoplasms - genetics - pathology |
2 |
|
liver neoplasms - pathology |
2 |
|
nanog |
2 |
|
nucleic acid hybridization |
2 |
|
p53 p21 |
2 |
|
polysaccharopeptide |
2 |
|
prostate tumor-initiating cells |
2 |
|
protein biosynthesis |
2 |
|
proto-oncogene proteins c-bcl-2 - genetics |
2 |
|
self-renewal |
2 |
|
stat3 |
2 |
|
stemness |
2 |
|
tetrazolium salts |
2 |
|
thiazoles |
2 |
|
tie-2 |
2 |
|
truncated hbx |
2 |
|
tumor suppressor protein p53 - genetics - metabolism |
2 |
|
tumor suppressor proteins |
2 |
